AlgometRx
Washington, US · Founded 2015 · Delaware corporation
AlgometRx develops the Nociometer, a medical device that analyzes pupil dilation in response to neuroselective stimulation to objectively characterize pain type, intensity, and the effect of analgesics. Spun out of Children's National Hospital, its technology serves clinicians for pain assessment and treatment decisions, and pharmaceutical companies for analgesic drug development.
Founders & leadership
AlgometRx was founded in 2015 by Julia Finkel.
JF
Julia FinkelFounder
DG
David GrossExecutive
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 3 rounds · 2017–2021
▶$875KraisedDec 2021 · 19 investors · Other TechnologyRule 506(b)
▶$875KraisedDec 2021 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Julia FinkelDirector
- David GrossExecutive Officer, Director
- David HellerDirector
- Offering amount
- $2M
- Amount sold
- $875K
- Minimum investment
- $10K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedNov 2017 · 12 investors · Other TechnologyRule 506(b)
▶$50KraisedNov 2017 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David GrossExecutive Officer, Director
- David HellerDirector
- Julia FinkelDirector
- Offering amount
- $300K
- Amount sold
- $50K
- Minimum investment
- $20K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1MraisedApr 2017 · 7 investors · Other TechnologyRule 506(b)
▶$1MraisedApr 2017 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Julia FinkelDirector
- David GrossExecutive Officer
- Offering amount
- $1.9M
- Amount sold
- $1M
- Minimum investment
- $25K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapRibometrix5 shared keywords
Caremetx3 shared keywordsCareMetx provides a patient access platform for pharmaceutical, biotech, and medical device manufacturers, connecting stakeholders across the treatment journey from benefit verification and prior authorization to therapy onboarding and adherence. Its technology includes a proprietary connection layer, an intelligence engine for next-best-action guidance, and a purpose-built CRM for reimbursement and field coordination workflows.
CareDx3 shared keywordsCareDx provides molecular diagnostic testing, workflow software, patient support, and pharmacy services for care teams working in transplant, cell therapy, and specialty oncology. Its products support rejection monitoring and complex care management in precision medicine.
Companies competing with AlgometRx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AlgometRx do?
- AlgometRx develops the Nociometer, a medical device that analyzes pupil dilation in response to neuroselective stimulation to objectively characterize pain type, intensity, and the effect of analgesics. Spun out of Children's National Hospital, its technology serves clinicians for pain assessment and treatment decisions, and pharmaceutical companies for analgesic drug development.
- Who founded AlgometRx?
- AlgometRx was founded by Julia Finkel in 2015.
- How much funding has AlgometRx raised?
- AlgometRx has disclosed $1.9M raised across 3 rounds.
- Where is AlgometRx headquartered?
- AlgometRx is headquartered in Washington, US.